NEUROBIOTECHNOLOGY-DRIVEN REGENERATIVE THERAPY FRAMEWORKS FOR POST-TRAUMATIC NEURAL RECOVERY

Abstract

This study addresses the problem that neurobiotechnology-driven regenerative therapies for post-traumatic neural injury often yield inconsistent recovery across organizations because framework implementation strength and its operational drivers are rarely measured and compared systematically. The purpose was to quantify Neurobiotechnology-Driven Regenerative Therapy Framework Strength (NDRTF) and test its association with Post-Traumatic Neural Recovery Outcomes (PNRO), and to identify which framework dimensions most strongly predict outcomes. Using a quantitative, cross-sectional, case-study-based design, a five-point Likert questionnaire was administered in three enterprise-scale case settings with technology-enabled monitoring and protocol tracking (Case A, B, C). The sample comprised 180 professionals (60 per case) spanning clinicians/therapists (52.8%), biomedical or neurotech staff (30.0%), and program coordinators (17.2%). Measurement quality was verified via reliability testing (α = 0.88 for the 25-item NDRTF scale; α = 0.86 for the 10-item PNRO scale). The analysis plan combined descriptive profiling, Pearson correlations, multiple regression, and case-specific regressions. Descriptively, overall NDRTF was moderate to high (M = 3.62, SD = 0.54) and PNRO was similar (M = 3.58, SD = 0.57), with Case A highest (NDRTF M = 3.74; PNRO M = 3.70) and Case C lowest (NDRTF M = 3.52; PNRO M = 3.49). Overall framework strength correlated strongly with recovery (r = 0.71, p < .001). In the multivariate model, the five NDRTF dimensions explained 59% of PNRO variance (R² = 0.59; F(5,174) = 49.30, p < .001), with Monitoring and Feedback Quality (β = 0.29, p < .001), Multidisciplinary Coordination (β = 0.23, p = .001), and Bio-Neurotech Integration (β = 0.19, p = .004) as the strongest predictors. Case models showed R² = 0.64 (A), 0.57 (B), and 0.49 (C). Implications include prioritizing monitoring feedback loops, cross-team coordination, and integrated biological plus neurotechnology delivery, supported by secure cloud data governance to sustain fidelity and scale outcomes.